lexingtonbiologo.jpg
Lexington Releases Audited Consolidated Financial Statements
30 avr. 2018 20h18 HE | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has...
lexingtonbiologo.jpg
Lexington Delivers 1st Generation HeartSentry for Clinical Trials
13 févr. 2018 09h00 HE | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...